05/05/2026
👁️ 𝗔 𝗚𝗲𝗻𝘁𝗹𝗲 𝗟𝗮𝘀𝗲𝗿 𝗳𝗼𝗿 𝗗𝗶𝗮𝗯𝗲𝘁𝗶𝗰 𝗘𝘆𝗲𝘀
Diabetic Macular Edema (DME) remains one of the leading causes of vision loss among people living with diabetes. While anti-VEGF injections are the standard of care, not all patients can receive or tolerate them — and that’s where subthreshold laser therapy offers new possibilities.
🩺 Case spotlight from Dr Lihteh Wu - Costa Rica:
A 75-year-old man with a 33-year history of type 2 diabetes presented with non-center-involved DME.
Because he lived far from the clinic, regular follow-up was challenging. He was treated with Lumibird Medical’s SubLiminal Laser, a subthreshold, tissue-sparing approach.
4 months later, his retinal thickening had completely resolved — with no retinal damage and no need for rescue therapy.
This case perfectly illustrates how SubLiminal Laser can provide safe, effective, and accessible care for diabetic patients, especially when regular treatments aren’t an option.
📖 Read the full article “Managing DME with Subthreshold Laser” by Dr. Lihteh Wu in Retina Today for more insights:https://www.subliminal-laser-therapy.com/wp-content/uploads/2025/05/AN_Dr.WU_RT_DME_2025.pdf
As World Diabetes Day comes to a close, let’s continue to innovate for better vision — and better lives.
